EconPapers    
Economics at your fingertips  
 

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

Yun Qiu, Lakshmeswari Ravi and Hsing-Jien Kung ()
Additional contact information
Yun Qiu: Case Western Reserve University, School of Medicine
Lakshmeswari Ravi: Case Western Reserve University, School of Medicine
Hsing-Jien Kung: Case Western Reserve University, School of Medicine

Nature, 1998, vol. 393, issue 6680, 83-85

Abstract: Abstract Interleukin-6 (IL-6) is a cytokine that was initially recognized as a regulator of immune and inflammatory responses1, but it also regulates the growth of many tumour cells, including prostrate carcinoma2,3,4. Overexpression of the growth-factor receptors ErbB2/neu and ErbB3 has been implicated in the neoplastic transformation of prostate carcinoma5,6,7. Here we show that treatment of the prostate cancer cell line LNCaP with IL-6 induces tyrosine phosphorylation of ErbB2 and ErbB3, but not ErbB1/EGFR. We also show that ErbB2 forms a complex with the gp130 subunit of the IL-6 receptor in an IL-6-dependent manner. This association is important because the inhibition of ErbB2 activity results in abrogation of IL-6-induced MAPK activation. Thus ErbB2 is a critical component of IL-6 signalling through the MAP kinase pathway. These data show how a cytokine receptor can diversify its signalling pathways by engaging with a growth-factor receptor kinase.

Date: 1998
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/30012 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:393:y:1998:i:6680:d:10.1038_30012

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/30012

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:393:y:1998:i:6680:d:10.1038_30012